Sustained Weight Management: Aids in the safe reduction of deep visceral fat accumulation by managing total daily caloric intake naturally.
Novo responded the same day, publicly characterizing the product as "illegal mass compounding that poses a significant risk to patient safety." On February 6, the FDA announced it would take action against companies mass-marketing unapproved compounded GLP-1 products, and HHS General Counsel stated publicly that the department had referred Hims to the DOJ for potential FDCA violations
Unexpected rapid weight loss (more than 23 pounds per week consistently) warrants a check-in with your care provider, as it may suggest underlying illness, excessive calorie restriction, or individual hypersensitivity
Moreover, TCM not only exhibits pharmacological activity that stimulates hair growth but also regulates hair follicle abnormalities through multi-pathway, multi-target, and multi-channel mechanisms
Effects of caffeine and caffeine withdrawal on mood and cognitive performance degraded by sleep restriction
But because the landscape around compounded GLP-1 medications has shifted dramatically since the FDA resolved the semaglutide shortage in February 2025, and what was once a straightforward decision now involves regulatory gray areas, legal battles, and quality control questions that most people never expected to navigate